I believe Herceptin is off patent.
If Roche and IMU trial Herr-Vaxx + Herceptin, can this combination be separately patented, and if so would this preclude the use of Herr-Vaxx with a Herceptin bio-similar?
If so, that would be a big incentive for Roche to partner with IMU!
Media Thread, page-1010
-
- There are more pages in this discussion • 13,555 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $376.9M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |